Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Stroup

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Schizophrenia Bulletin|February 5, 2008
Randomized controlled trials for schizophrenia: study designs targeted to distinct goalsT Scott Stroup, John R Geddes
Schizophrenia Bulletin|September 12, 2012
Paliperidone palmitate for schizophreniaAbraham M Nussbaum, T Scott Stroup
Evidence-Based Mental Health|April 10, 2015
Effectiveness of long-acting injectable antipsychotics: a clinical perspectiveEnrico G Castillo, T Scott Stroup
The Australian and New Zealand Journal of Psychiatry|April 5, 2017
Raising the standard of care for schizophrenia is an achievable goalT Scott Stroup, Jeffrey A Lieberman
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 8, 2013
The enduring challenge of antipsychotic non-adherenceT Scott Stroup, Lisa B Dixon
The New England Journal of Medicine|May 4, 2002
Prevention of relapse in schizophreniaJeffrey Lieberman, Scott Stroup, Lon Schneider
Schizophrenia Bulletin|August 12, 2003
Guest editors' introduction: what can large pragmatic clinical trials do for public mental health care?Jeffrey A Lieberman, T Scott Stroup
Schizophrenia Bulletin|March 21, 2003
Concealed medicines for people with schizophrenia: a U.S. perspectiveScott Stroup, Marvin Swartz, Paul Appelbaum
The American Journal of Psychiatry|March 3, 2015
Medications for first-episode psychosis: making a good startLisa B Dixon, T Scott Stroup
The American Journal of Psychiatry|January 9, 2014
Response to RosenfeldL Fredrik Jarskog, T Scott Stroup
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Schizophrenia Bulletin|February 5, 2008
Randomized controlled trials for schizophrenia: study designs targeted to distinct goalsT Scott Stroup, John R Geddes
Schizophrenia Bulletin|September 12, 2012
Paliperidone palmitate for schizophreniaAbraham M Nussbaum, T Scott Stroup
Evidence-Based Mental Health|April 10, 2015
Effectiveness of long-acting injectable antipsychotics: a clinical perspectiveEnrico G Castillo, T Scott Stroup
The Australian and New Zealand Journal of Psychiatry|April 5, 2017
Raising the standard of care for schizophrenia is an achievable goalT Scott Stroup, Jeffrey A Lieberman
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 8, 2013
The enduring challenge of antipsychotic non-adherenceT Scott Stroup, Lisa B Dixon
The New England Journal of Medicine|May 4, 2002
Prevention of relapse in schizophreniaJeffrey Lieberman, Scott Stroup, Lon Schneider
Schizophrenia Bulletin|August 12, 2003
Guest editors' introduction: what can large pragmatic clinical trials do for public mental health care?Jeffrey A Lieberman, T Scott Stroup
Schizophrenia Bulletin|March 21, 2003
Concealed medicines for people with schizophrenia: a U.S. perspectiveScott Stroup, Marvin Swartz, Paul Appelbaum
The American Journal of Psychiatry|March 3, 2015
Medications for first-episode psychosis: making a good startLisa B Dixon, T Scott Stroup
The American Journal of Psychiatry|January 9, 2014
Response to RosenfeldL Fredrik Jarskog, T Scott Stroup
Pageof 17